Wenzhu Hu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 20, 2026
The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015-2025).
Journal: Theranostics
Published: December 19, 2025
Preclinical Development and Comparison of [99mTc]Tc/[177Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Cancer Theranostics.
Journal: Molecular pharmaceutics
Published: October 15, 2025
Glypican-3-targeted immunoPET imaging of hepatocellular carcinoma: a translational study.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 11, 2025
PET Imaging of Cardiac Inflammation in Viral Myocarditis Using a DPP4-Targeted Probe.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 01, 2025
Design, Synthesis, and Evaluation of OncoFAP Derivatives with the Albumin Binder as Novel Antitumor Radiopharmaceuticals.
Journal: Chemical & biomedical imaging
Published: July 28, 2025
Peptide-Based PET Imaging Differentiates Netrin-1 Expression in Tumors.
Journal: Molecular pharmaceutics
Published: June 23, 2025
EGFR Targeted Liposomal PROTAC Assisted With Epigenetic Regulation as an Efficient Strategy for Osimertinib-Resistant Lung Cancer Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 03, 2025
Glypican-3-Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 21, 2025
Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis.
Journal: Molecular pharmaceutics
Published: March 25, 2025
Last Updated: 09/26/2026